Nephros (NEPH) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free NEPH Stock Alerts $2.19 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Nephros Short Interest DataCurrent Short Volume1,600 sharesPrevious Short Volume2,600 sharesChange Vs. Previous Month-38.46%Dollar Volume Sold Short$3,184.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares10,540,000 sharesFloat Size9,180,000 sharesShort Percent of Float0.02%Today's Trading Volume476 sharesAverage Trading Volume14,162 sharesToday's Volume Vs. Average3% Short Selling Nephros ? Sign up to receive the latest short interest report for Nephros and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNEPH Short Interest Over TimeNEPH Days to Cover Over TimeNEPH Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Nephros Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,600 shares $3,184.00 -38.5%0.0%0.1 $1.99 3/31/20242,600 shares $5,694.00 +44.4%0.0%0.1 $2.19 3/15/20241,800 shares $3,906.00 -64.7%0.0%0.1 $2.17 2/29/20245,100 shares $16,116.00 +24.4%0.1%0.2 $3.16 2/15/20244,100 shares $14,391.00 -40.6%0.0%0.1 $3.51 1/31/20246,900 shares $24,495.00 -24.2%0.1%0.2 $3.55 Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,100 shares $31,213.00 -18.0%0.1%0.3 $3.43 12/31/202311,100 shares $38,406.00 -57.3%0.1%0.4 $3.46 12/15/202326,000 shares $74,880.00 -14.8%0.3%1.1 $2.88 11/30/202330,500 shares $69,845.00 +23.0%0.3%2.7 $2.29 11/15/202324,800 shares $51,336.00 +10.7%0.3%2.9 $2.07 10/31/202322,400 shares $36,957.76 -27.7%0.2%2.5 $1.65 10/15/202331,000 shares $50,840.00 +36.0%0.3%3.7 $1.64 9/30/202322,800 shares $33,744.00 -24.0%0.3%2.7 $1.48 9/15/202330,000 shares $42,600.00 -19.8%0.3%4.5 $1.42 8/31/202337,400 shares $61,336.00 -13.0%0.4%3.7 $1.64 8/15/202343,000 shares $64,930.00 +80.7%0.5%0.6 $1.51 7/31/202323,800 shares $32,844.00 -5.9%0.3%0.3 $1.38 7/15/202325,300 shares $35,420.00 -10.6%0.3%0.3 $1.40 6/30/202328,300 shares $43,865.00 -6.0%0.3%0.4 $1.55 6/15/202330,100 shares $44,849.00 +51.3%0.3%0.4 $1.49 5/31/202319,900 shares $31,840.00 +9.9%0.2%0.2 $1.60 5/15/202318,100 shares $22,697.40 -13.8%0.2%1.1 $1.25 4/30/202321,000 shares $29,820.00 -7.9%0.2%1.3 $1.42 4/15/202322,800 shares $32,376.00 -4.6%0.3%1.3 $1.42 3/31/202323,900 shares $25,570.61 +17.7%0.3%1.3 $1.07 3/15/202320,300 shares $20,503.00 -18.8%0.2%1 $1.01 2/28/202325,000 shares $27,250.00 +12.6%0.3%1.1 $1.09 2/15/202322,200 shares $29,304.00 +30.6%N/A0.8 $1.32 1/31/202317,000 shares $22,948.30 -32.5%N/A0.6 $1.35 1/15/202325,200 shares $29,736.00 +50.9%N/A0.9 $1.18 12/30/202216,700 shares $19,325.24 -51.2%N/A0.6 $1.16 12/15/202234,200 shares $37,339.56 +12.1%N/A1.2 $1.09 11/30/202230,500 shares $31,720.00 +64.0%N/A1.1 $1.04 11/15/202218,600 shares $19,768.08 -14.3%N/A0.3 $1.06 10/31/202221,700 shares $22,785.00 -35.6%N/A0.4 $1.05 10/15/202233,700 shares $38,418.00 +15.4%N/A0.6 $1.14 9/30/202229,200 shares $26,572.00 +15.0%0.3%0.5 $0.91 9/15/202225,400 shares $30,734.00 -52.3%0.3%0.4 $1.21 8/31/202253,200 shares $75,012.00 +51.1%0.6%1 $1.41Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. NEPH Short Interest - Frequently Asked Questions What is Nephros' current short interest? Short interest is the volume of Nephros shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,600 shares of NEPH short. 0.02% of Nephros' shares are currently sold short. Learn More on Nephros' current short interest. What is a good short interest percentage for Nephros? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Nephros' floating shares are currently sold short. Is Nephros' short interest increasing or decreasing? Nephros saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 1,600 shares, a drop of 38.5% from the previous total of 2,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nephros' float size? Nephros currently has issued a total of 10,540,000 shares. Some of Nephros' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nephros currently has a public float of 9,180,000 shares. How does Nephros' short interest compare to its competitors? 0.02% of Nephros' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Nephros: PolyPid Ltd. (0.15%), Inspira Technologies Oxy B.H.N. Ltd. (1.49%), GlucoTrack, Inc. (0.51%), Akili, Inc. (0.15%), STRATA Skin Sciences, Inc. (0.86%), Meihua International Medical Technologies Co., Ltd. (1.61%), SeaStar Medical Holding Co. (6.36%), PAVmed Inc. (5.35%), Femasys Inc. (5.84%), T2 Biosystems, Inc. (6.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Nephros stock? Short selling NEPH is an investing strategy that aims to generate trading profit from Nephros as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nephros? A short squeeze for Nephros occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NEPH, which in turn drives the price of the stock up even further. How often is Nephros' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEPH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PolyPid Short Squeeze Inspira Technologies Oxy B.H.N. Short Squeeze GlucoTrack Short Squeeze Akili Short Squeeze STRATA Skin Sciences Short Squeeze Meihua International Medical Technologies Short Squeeze SeaStar Medical Short Squeeze PAVmed Short Squeeze Femasys Short Squeeze T2 Biosystems Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NEPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings